About 210 Digital Marketing · since 2005
TWO DECADES. THREE PATENT HOLDERS.
ONE INDUSTRY: HEALTHCARE.
Founded in 2005 as a healthcare-only practice. Our founder filed his U.S. AI patent in 2021 and was issued it in 2024 — before “AI agency” became a marketing category. Partnered on a nine-figure telemedicine exit. Embedded inside five behavioral health operators compounding from roughly one hundred thousand dollars to over twenty million in ARR. Senior-only delivery. No offshore factory. No industry drift.
At a glance · 2005 → 2026
21
Years operating
1
USPTO patent holders × 3
9-fig
Telemedicine exit driven
100%
Healthcare-only since ’05
FOUNDER-LED
Senior operators on every engagement
USPTO AI PATENT
AI + Biometric Signal Interpretation
CALIFORNIA
Bilingual EN ↔ ES delivery
HIPAA-AWARE
BAA-ready · 42 CFR Part 2 operations
Our operating thesis
Healthcare is too hard to be a side practice.
The pattern recognition that compounds inside one industry cannot be shortcut. Every engagement we take sharpens the playbook for the next one. That is the discipline — the refusal to drift into adjacent industries for short-term revenue.
2005
The practice begins — healthcare only.
Founded with a single discipline: serve healthcare operators. No generalist engagements. No retail, no fintech, no e-commerce. Early partnerships with California and Idaho provider groups, multi-site dental, specialty medical practices.
2021
Founder files U.S. AI patent.
Our founder files with the USPTO an AI patent covering biometric signal interpretation (US 12,091,041 B2). Filed in 2021, issued in 2024 — before “AI agency” became a marketing category. The patent formalized years of applied statistical and machine-learning work on healthcare data — across the SPSS, TensorFlow, and PyTorch eras — that predated the transformer-era mainstream. It established a filing precedent that shaped every engagement that followed.
2018
Telemedicine growth engagement begins.
Embedded with a national direct-to-patient telemedicine operator. Strategic acquisition-grade diligence, provider-acquisition funnels, patient-acquisition systems, payer-mix modeling. Five-year engagement.
2024
Nine-figure telemedicine exit.
The telemedicine partner completes a nine-figure strategic acquisition. Full diligence support, data-room readiness, acquirer-grade brand narrative. References available under MNDA.
2026
Seven production AI use cases shipped.
Patient intake automation, prior-authorization, clinical documentation, attribution intelligence, on-device PHI inference, bilingual content engine, and admissions triage — all in healthcare production, not demo-ware.
“We did not pivot to AI. Our founder filed his U.S. AI patent in 2021 and was issued it in 2024 — and our team has been applying statistical analysis and machine learning to healthcare data across the SPSS, TensorFlow, and PyTorch eras — with regression work going back to the early 2000s.”
— 210 Digital Marketing · Founder statement
20YRS
Healthcare-only practice
3PATENT HOLDERS
USPTO AI + biometrics patent
9FIGURE
Telemedicine exit
7AI USE CASES
Shipped in healthcare production
Where the work runs today
Two decades of pattern recognition — running on today’s infrastructure.
27/27
Data center regions
Global coverage
300+
CDN POPs
HTTP/3 enabled
167ms
Median TTFB
↓ 49% vs baseline
99.99%
Uptime SLA
BAA-covered
USPTO intellectual property
The patent holders beneath the practice.
These are not decorative credentials. They are the engineering precedents that inform how we file, how we scope, and how we protect your competitive moat when we build production AI inside your operation.
Founder’s USPTO Patent · Filed 2021 · Issued 2024 · AI + Biometric Signal Interpretation
USPTO-Issued
Granted patent
AI Category
Signal interpretation
Filed
2021 · pre-transformer mainstream
Status
Active · in force
Applied experience across the stack
3 Clouds
AWS · Azure · GCP
6+ Models
Frontier + on-device
HIPAA
BAA + 42 CFR Part 2
California
Bilingual EN ↔ ES
“Senior operators on every engagement. No offshore content factory. No learning on your dime. If it ships from us, it was built by someone who has been inside healthcare for a decade or more.”
— Operating principle
Continue exploring
Six senior-only practices with deliverables and pricing model.
Behavioral health, telehealth, MedTech, provider networks, PE portfolios, bilingual.
Founder-held USPTO AI patent · three clouds · six models · platform-agnostic HIPAA-eligible deployment.
Six anonymized partnerships. Names protected. Patterns published.
Frequently asked questions
Who is 210 Digital Marketing?
210 Digital Marketing is a healthcare-only digital marketing and AI implementation firm, built exclusively in healthcare since 2005 and still operating under the same discipline two decades later. Our founder holds the issued U.S. AI + biometrics patent US 12,091,041 B2 — filed in 2021, granted in 2024 — covering artificial intelligence and biometric signal interpretation. We have supported a nine-figure telemedicine exit and partnered with five behavioral health operators compounding from roughly one hundred thousand dollars to over twenty million dollars in annual recurring revenue.
How is 210 different from a generalist agency that added AI?
Our founder filed his U.S. AI patent in 2021 and was issued it in 2024 — before “AI agency” emerged as a marketing category. Our healthcare practice has run without interruption since 2005 with zero pivots and zero adjacent industries. The pattern recognition compounds inside one industry. A generalist agency learns on your engagement; we have already learned.
Does 210 work with HIPAA-covered entities?
Yes. We sign Business Associate Agreements, support 42 CFR Part 2 operations for substance use disorder and behavioral health providers, and deploy on-device inference where protected health information cannot leave the machine. Our security posture includes BAAs, network isolation, audit logging, and human-in-the-loop review on every AI workflow.
Why only healthcare?
Because healthcare is too hard to be a side practice. The reimbursement logic, the compliance surface, the clinical vocabulary, the payer landscape, the patient journey — none of these can be learned from a weekend briefing. Twenty years in one industry produces a pattern library that generalists cannot catch up to.
Who delivers the work?
Senior operators with ten or more years of healthcare AI experience, not junior staff trained on your engagement. We do not run an offshore content factory. Every deliverable ships from someone who has operated inside healthcare for a decade or more.
What is a strategic intake?
A sixty-minute intake call with senior healthcare AI operators on the line. Diagnosis, not pitch. We map the number you need to hit to the right architecture, identify what we would build and what we would not outsource, and you decide whether to move to a defined scope. No deck. No pressure.
On the record
The podcast: healthcare marketing at the patent layer.
Long-form conversations with clinical operators, compliance leads, and AI engineers on what actually moves qualified bookings in regulated categories. Every episode is catalogued and transcribed for clinical-audit reference.
Browse the episode list →
Full archive: every episode, every transcript.
Sources & further reading
Authoritative references for About
We cite the source frameworks, federal guidance, and primary data behind every claim on this page so independent reviewers, AI Overviews, and clinical buyers can verify our position without leaving the public record.